Clinical trial No longer in our active list Phase 1 Interventional Ages 21 and up

Improving walking in Parkinson's patients with new brain stimulation techniques

Official title: ENGAGE-PD: Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease

Run by The Cleveland Clinic · NCT05022147 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new brain stimulation technique to see if it can help people with Parkinson's walk better and feel more stable.

Quick facts

PhasePhase 1
Study typeInterventional
Ages21 Years and up
SexAll
Enrollment12 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
Trial IDNCT05022147 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with Parkinson Disease who have bilateral STN DBS and experience balance or walking impairments.

Probably not a fit

Patients who are severely dependent on walking aids or have significant comorbid conditions affecting gait may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of alternating-frequency Deep Brain Stimulation (DBS) in enhancing gait and reducing postural instability in patients with Parkinson Disease. Participants will engage in gait tasks while their body movements and neural signals are recorded, allowing researchers to assess the impact of different stimulation frequencies. The study addresses a critical need, as current treatments for gait disorders in Parkinson's are often inadequate. By exploring this innovative approach, the research seeks to develop better therapies for managing these debilitating symptoms.

Why it matters

Potential benefit: If successful, this study could lead to improved mobility and reduced fall risk for patients with Parkinson Disease.

How similar studies have gone: While there have been studies on DBS for Parkinson's, this specific approach using alternating frequencies is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Bilateral STN DBS for PD
* Medtronic Percept PC implanted DBS battery/pulse generator/recording system
* Presence of balance and/or walking impairment and/or freezing of gait
* Can walk without assistance, OFF meds, based on yes/no verbal response

Exclusion Criteria:

* Severity of gait impairment should not require dependency to walker or cane
* Cannot tolerate monopolar stimulation at either of the two middle electrode contacts (prerequisite for the recording mode of the DBS) at high frequency (130 Hz) or low frequency (60 Hz).
* Concomitant conditions that may affect significantly the evaluation of balance or gait, including orthopedic, rheumatologic or other neurological diseases
* Contraindication to physical therapy
* Age \< 21
* Diagnosis of dementia
* Not agreeable to having video taken of entire research visit

Where it's running

  • Cleveland Clinic Foundation
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: James Liao, MD PhD — The Cleveland Clinic
  • Study coordinator: James Liao, MD PhD
  • Email: liaoj2@ccf.org
  • Phone: 216-445-1108

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.